Stock listing

Lisata Therapeutics, Inc.

Selected listing: A3DWGC · LSX · EUR · DE

Lisata Therapeutics, Inc. (LS Exchange: A3DWGC), Health Technology. Latest release Oct 5, 2026: Marea Therapeutics, a Subsidiary of Lisata Therapeutics…

A3DWGC:LSXEURDEUpdated October 2, 2026

Ticker: LS Exchange: A3DWGC
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LS Exchange
Currency: EUR

Latest news from Lisata Therapeutics, Inc.

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly

October 5, 2026

Lisata Therapeutics Announces Acquisition of Marea Therapeutics and $225 Million Concurrent Private Placement

September 17, 2026

Lisata Therapeutics Provides Update Following Termination of Merger Agreement

August 4, 2026

Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc.

June 10, 2026

Kuva Intends to Commence Tender Offer for Lisata Therapeutics by May 29, 2026

May 4, 2026

All Lisata Therapeutics, Inc. news →

Events

Replays

Lisata Therapeutics, Inc. (LSTA) Q3 2025 Earnings Call
Thu, Nov 06, 2025 · 04:30 PM ET
Watch
Lisata Therapeutics, Inc. (LSTA) Q2 2025 Earnings Call
Thu, Aug 07, 2025 · 04:30 PM ET
Watch
Lisata Therapeutics, Inc. (LSTA) Q1 2025 Earnings Call
Thu, May 08, 2025 · 04:30 PM ET
Watch

Research Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc. company profile

View the public company page for Lisata Therapeutics, Inc. on 6ix.

Lisata Therapeutics, Inc. news

Read company news and market updates connected to Lisata Therapeutics, Inc..

Lisata Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Lisata Therapeutics, Inc..